Mary Ellen Urick

1.7k total citations · 1 hit paper
22 papers, 1.3k citations indexed

About

Mary Ellen Urick is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology. According to data from OpenAlex, Mary Ellen Urick has authored 22 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Obstetrics and Gynecology. Recurrent topics in Mary Ellen Urick's work include Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Estrogen and related hormone effects (3 papers). Mary Ellen Urick is often cited by papers focused on Endometrial and Cervical Cancer Treatments (7 papers), Ovarian cancer diagnosis and treatment (5 papers) and Estrogen and related hormone effects (3 papers). Mary Ellen Urick collaborates with scholars based in United States, Canada and Spain. Mary Ellen Urick's co-authors include Daphne W. Bell, Patricia A. Johnson, Meghan L. Rudd, Maria J. Merino, Dennis C. Sgroi, James R. Giles, James C. Mullikin, Nancy F. Hansen, Matthieu Le Gallo and Andrew K. Godwin and has published in prestigious journals such as Nature Genetics, Nature reviews. Cancer and PLoS ONE.

In The Last Decade

Mary Ellen Urick

21 papers receiving 1.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical actionability of molecular targets in endometrial cancer

2019 293 citations Mary Ellen Urick, Daphne W. Bell Nature reviews. Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Ellen Urick United States	16	672	352	339	330	227	22	1.3k
Lisa Gangi United States	12	671 1.0×	242 0.7×	275 0.8×	116 0.4×	250 1.1×	15	1.1k
Michele Cummings United Kingdom	18	384 0.6×	171 0.5×	171 0.5×	82 0.2×	290 1.3×	36	933
Rama Soundararajan United States	10	403 0.6×	242 0.7×	77 0.2×	66 0.2×	263 1.2×	18	760
Takeshi Motohara Japan	14	634 0.9×	333 0.9×	186 0.5×	66 0.2×	427 1.9×	29	1.1k
Frank Markland United States	9	426 0.6×	118 0.3×	256 0.8×	36 0.1×	231 1.0×	11	880
Laura A. Rudolph‐Owen United States	10	763 1.1×	336 1.0×	71 0.2×	32 0.1×	361 1.6×	12	1.2k
Wei-Lei Yang United States	11	1.1k 1.7×	360 1.0×	108 0.3×	26 0.1×	403 1.8×	11	1.5k
Leizhen Wei United States	17	1.2k 1.8×	205 0.6×	69 0.2×	24 0.1×	466 2.1×	20	1.4k
Yunping Lu China	18	762 1.1×	324 0.9×	68 0.2×	19 0.1×	287 1.3×	77	1.1k

Countries citing papers authored by Mary Ellen Urick

Since Specialization

Citations

This map shows the geographic impact of Mary Ellen Urick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ellen Urick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ellen Urick more than expected).

Fields of papers citing papers by Mary Ellen Urick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ellen Urick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ellen Urick. The network helps show where Mary Ellen Urick may publish in the future.

Co-authorship network of co-authors of Mary Ellen Urick

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ellen Urick. A scholar is included among the top collaborators of Mary Ellen Urick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ellen Urick. Mary Ellen Urick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rudd, Meghan L., Nancy F. Hansen, Xiaolu Zhang, et al.. (2022). KLF3 and PAX6 are candidate driver genes in late-stage, MSI-hypermutated endometrioid endometrial carcinomas. PLoS ONE. 17(1). e0251286–e0251286. 2 indexed citations

Urick, Mary Ellen, Eun‐Jeong Yu, & Daphne W. Bell. (2021). High‐risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels. Cancer. 127(16). 2905–2915. 10 indexed citations

Urick, Mary Ellen & Daphne W. Bell. (2020). Proteomic profiling of FBXW7‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target. Cancer Medicine. 9(11). 3863–3874. 9 indexed citations

Urick, Mary Ellen & Daphne W. Bell. (2019). Clinical actionability of molecular targets in endometrial cancer. Nature reviews. Cancer. 19(9). 510–521. 293 indexed citations breakdown →

Urick, Mary Ellen & Daphne W. Bell. (2018). In vitro effects of FBXW7 mutation in serous endometrial cancer: Increased levels of potentially druggable proteins and sensitivity to SI‐2 and dinaciclib. Molecular Carcinogenesis. 57(11). 1445–1457. 13 indexed citations

Gallo, Matthieu Le, Meghan L. Rudd, Mary Ellen Urick, et al.. (2017). Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing. Cancer. 123(17). 3261–3268. 63 indexed citations

Gallo, Matthieu Le, Meghan L. Rudd, Mary Ellen Urick, et al.. (2017). The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas. Cancer. 124(1). 65–73. 28 indexed citations

Rudd, Meghan L., Hassan Mohamed, Jessica C. Price, et al.. (2014). Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1. BMC Cancer. 14(1). 884–884. 12 indexed citations

Eddy, Sean, Mary Ellen Urick, Nickolay A. Khazanov, et al.. (2013). Abstract C256: Expanded clinical opportunities for crizotinib from an analysis of over 5,000 cancer patient exomes.. Molecular Cancer Therapeutics. 12(11_Supplement). C256–C256.

10.

Chung, Eun Joo, Mary Ellen Urick, Naamit Kurshan, et al.. (2013). MEK1/2 inhibition enhances the radiosensitivity of cancer cells by downregulating survival and growth signals mediated by EGFR ligands. International Journal of Oncology. 42(6). 2028–2036. 15 indexed citations

11.

Citrin, Deborah E., Ying J. Hitchcock, Eun Joo Chung, et al.. (2012). Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies. Radiation Oncology. 7(1). 51 indexed citations

12.

Urick, Mary Ellen, Meghan L. Rudd, Andrew K. Godwin, et al.. (2011). PIK3R1 (p85α) Is Somatically Mutated at High Frequency in Primary Endometrial Cancer. Cancer Research. 71(12). 4061–4067. 162 indexed citations

13.

Urick, Mary Ellen, Eun Joo Chung, William P. Shield, et al.. (2011). Enhancement of 5-Fluorouracil-induced In Vitro and In Vivo Radiosensitization with MEK Inhibition. Clinical Cancer Research. 17(15). 5038–5047. 37 indexed citations

14.

Treviño, Lindsey S., James R. Giles, Wei Wang, Mary Ellen Urick, & Patricia A. Johnson. (2010). Gene Expression Profiling Reveals Differentially Expressed Genes in Ovarian Cancer of the Hen: Support for Oviductal Origin?. Hormones and Cancer. 1(4). 177–186. 35 indexed citations

15.

Giles, James R., Robert G. Elkin, Lindsey S. Treviño, et al.. (2010). The Restricted Ovulator Chicken. International Journal of Gynecological Cancer. 20(5). 738–744. 22 indexed citations

16.

Brown, Aaron, Eun Joo Chung, Mary Ellen Urick, et al.. (2010). Evaluation of the fullerene compound DF-1 as a radiation protector. Radiation Oncology. 5(1). 34–34. 28 indexed citations

17.

Johnson, Patricia A., Tera R. Kent, Mary Ellen Urick, Lindsey S. Treviño, & James R. Giles. (2009). Expression of anti-Mullerian hormone in hens selected for different ovulation rates. Reproduction. 137(5). 857–863. 33 indexed citations

18.

Urick, Mary Ellen, James R. Giles, & Patricia A. Johnson. (2008). VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer. Gynecologic Oncology. 110(3). 418–424. 29 indexed citations

19.

Johnson, Patricia A., Tera R. Kent, Mary Ellen Urick, & James R. Giles. (2007). Expression and Regulation of Anti-Mullerian Hormone in an Oviparous Species, the Hen1. Biology of Reproduction. 78(1). 13–19. 52 indexed citations

20.

Urick, Mary Ellen & Patricia A. Johnson. (2006). Cyclooxygenase 1 and 2 mRNA and protein expression in the Gallus domesticus model of ovarian cancer. Gynecologic Oncology. 103(2). 673–678. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact